Sun Pharma Advanced Research Co. Ltd. NSE:SPARC

Press Release Nov 18 2022

Published November 18, 2022 at 2:33 p.m. UTC

Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 18-Nov-2022 titled Press Release: SEZABY TM (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

View Attachment